Vaughan DE - Search Results

1

Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men.

Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1687-90. Arterioscler Thromb Vasc Biol. 1997. PMID: 9327764

2

Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator.

Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. JAMA. 1994 Sep 28;272(12):929-33. doi: 10.1001/jama.1994.03520120039028. JAMA. 1994. PMID: 7794308

3

Prospective study of endogenous tissue plasminogen activator and risk of stroke.

Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. Lancet. 1994 Apr 16;343(8903):940-3. doi: 10.1016/s0140-6736(94)90064-7. Lancet. 1994. PMID: 7909008

4

Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. Lancet. 1993 May 8;341(8854):1165-8. doi: 10.1016/0140-6736(93)90998-v. Lancet. 1993. PMID: 8098074

5

A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.

Ridker PM, Vaughan DE, Stampfer MJ, Sacks FM, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. Arterioscler Thromb. 1993 Nov;13(11):1587-92. doi: 10.1161/01.atv.13.11.1587. Arterioscler Thromb. 1993. PMID: 8218099 Clinical Trial.

6

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.

Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH. Ridker PM, et al. Among authors: vaughan de. Circulation. 1992 May;85(5):1822-7. doi: 10.1161/01.cir.85.5.1822. Circulation. 1992. PMID: 1572039

7

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.

Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. Circulation. 1993 Jun;87(6):1969-73. doi: 10.1161/01.cir.87.6.1969. Circulation. 1993. PMID: 8504511

8

Hemostatic factors and the risk of myocardial infarction.

Ridker PM, Vaughan DE. Ridker PM, et al. Among authors: vaughan de. N Engl J Med. 1995 Aug 10;333(6):389; author reply 389-90. N Engl J Med. 1995. PMID: 7609765 No abstract available.

9

An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation.

Coffey CS, Hebert PR, Ritchie MD, Krumholz HM, Gaziano JM, Ridker PM, Brown NJ, Vaughan DE, Moore JH. Coffey CS, et al. Among authors: vaughan de. BMC Bioinformatics. 2004 Apr 30;5:49. doi: 10.1186/1471-2105-5-49. BMC Bioinformatics. 2004. PMID: 15119966 Free PMC article.

10

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.

Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA. Vaughan DE, et al. Circulation. 1997 Jul 15;96(2):442-7. doi: 10.1161/01.cir.96.2.442. Circulation. 1997. PMID: 9244210 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters